Investors

Dr. Leopold Arfors holds an M.D. from the Karolinska Institute in Stockholm, Sweden, where he also earned his Ph.D. He is board certified in clinical immunology, as well as internal medicine with sub-specialization in rheumatology and has served in that capacity for many years at the Karolinska University Hospital in Stockholm. His experience also entails several years at the SBL immunological laboratory and consultancy rheumatology at the Kronan pain clinic in Stockholm.

His pharmaceutical industry experience dates back to 1995, when he joined the Swedish company Astra; which through a merger became part of AstraZeneca. Prior to joining Medwell Capital, Dr. Arfors was the Product Medical Director at AstraZeneca, heading the clinical development of drugs for MS and other autoimmune diseases. He was also a member of AstraZeneca’s MS disease area specialist team for validation of potential biomarkers for MS clinical trials and evaluation of in-licensing opportunities.